Clinical Trial Update: Study of ONT-10 and Varlilumab to Treat Advanced Ovarian or Breast Cancer [Phase 1]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 1 study evaluating ONT-10 in combination with varlilumab for advanced breast and ovarian cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Ovarian Cancer

Drugs mentioned

• ONT-10
• Varlilumab (varlilumab)

Snippet

Sponsor: Cascadian Therapeutics Inc. | Conditions: Advanced Breast Carcinoma, Advanced Ovarian Carcinoma | Phase 1 | Status: COMPLETED